Clinical Scorecard: 1 in 4 US Army men may screen low for testosterone
At a Glance
| Category | Detail |
|---|---|
| Condition | Low morning total testosterone concentrations in active-duty US Army men |
| Key Mechanisms | Age and BMI were associated with higher odds of testosterone concentrations below the study thresholds; illness, obesity, and physical stress can influence testosterone concentrations. |
| Target Population | Active-duty US Army men; the analysis included 479 participants with fasting morning testosterone measurements. |
| Care Setting | Military health screening and clinical evaluation; the study assessed prevalence estimates, not diagnosis of hypogonadism. |
Key Highlights
- An estimated 25.7% had morning total testosterone below 300 ng/dL; 14.7% were below 264 ng/dL.
- The weighted mean morning total testosterone concentration was 405 ng/dL.
- Low concentrations were more common among men aged 30 years or older than among younger men at both thresholds.
- Each 5-unit increase in BMI was associated with 90% higher odds of concentrations below 300 ng/dL and 82% higher odds below 264 ng/dL.
- The authors cautioned that screening estimates should not be interpreted as the prevalence of hypogonadism.
Guideline-Based Recommendations
Diagnosis
- Current clinical guidelines recommend testosterone testing only for men with compatible signs or symptoms.
- Interpretation should account for factors that can influence testosterone concentrations, including obesity, illness, and physical stress.
Management
- Low morning testosterone concentrations require confirmation with repeat testing because of intraindividual and diurnal variation.
Monitoring & Follow-up
- The article reports a new military policy requiring annual testosterone screening for active-duty and reserve personnel aged 30 years or older.
Risks
- A single measurement may misclassify testosterone status, particularly near clinical thresholds.
- The cross-sectional design does not establish causality, and the study estimates do not represent the prevalence of hypogonadism.
Patient & Prescribing Data
The study included 479 active-duty men, excluding 3 receiving testosterone replacement therapy; weighted mean age was 29.9 years and mean BMI was 28.4.
The article reports prevalence estimates and screening considerations, not treatment recommendations or prescribing outcomes.
Clinical Best Practices
- Test testosterone when compatible signs or symptoms are present, consistent with current clinical guidelines.
- Confirm a low morning concentration with repeat testing.
- Consider obesity, illness, and physical stress when interpreting testosterone results.
- Do not equate a low screening measurement with a diagnosis of hypogonadism.
Related Resources & Content
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
